Şirket yükleniyor
Just reported
Q3 2026 results
From LifeStance Health's results release of 5 Kasım 2026; its quarterly report has since been filed.
Revenue
Actual
$455,9M
+%25 y/y
+%4,7 q/qGuided
$430M
midpoint
Above guide+%6,0Operating income, GAAP
Actual
$33,1M
+%346 y/y
+%7,9 q/qGuided
—
No guide given
Company outlook
Q4 2026
- Revenue$446M – $466M+%19 y/y First given
Full year 2026
- Revenue$1,741B – $1,761B+%23 y/y Raised +%2,7
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Keep exploring
The themes LifeStance Health is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Highest-graded in Medical Care Facilities
Graded A or B and worth $2B or more: A first, then the largest.
THCTenet Healthcare Corp.$23,3BA+
EHCEncompass Health Corporation$14BA+
ENSGEnsign Group, Inc.$10,9BA
PACSPACS Group, Inc.$7,9BA
CONConcentra Group Holdings Parent, Inc.$5,5BA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21 Eki 2026CBGraded C, now B
MCKMckesson Corporation4 Kas 2026BAGraded B, now A
CVSCVS Health Corp4 Kas 2026BAGraded B, now A
EWEdwards Lifesciences Corporation4 Kas 2026BAGraded B, now A
BIIBBiogen Inc.28 Eki 2026BAGraded B, now A
LifeStance Health Group, Inc. şirketinin ABD Menkul Kıymetler ve Borsa Komisyonu’na (SEC) sunduğu kendi belgelerinden kuruldu. Rakamlar bildirildiği gibidir; hisse başına geçmiş bugünkü hisse tabanına göre yeniden hesaplanmıştır. Bu bir işletmeyi anlatır — yatırım tavsiyesi değildir ve alma ya da satma önerisi değildir.
